INSULET CORPORATION Interest Expense
INSULET CORPORATION (PODD) reported Interest Expense of $10.70 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-10
- INSULET CORPORATION interest expense for the quarter ending 2024-03-31 was $10.70M, a 13.83% increase year-over-year.
- INSULET CORPORATION interest expense for the quarter ending 2023-12-31 was $6.70M, a 22.99% decline year-over-year.
- INSULET CORPORATION interest expense for the quarter ending 2023-09-30 was $10.40M, a 13.04% increase year-over-year.
- INSULET CORPORATION interest expense for the quarter ending 2023-06-30 was $9.70M, a 6.59% increase year-over-year.
- INSULET CORPORATION interest expense for fiscal 2023 was $36.20M, a 0.56% increase from fiscal 2022.
- INSULET CORPORATION interest expense for fiscal 2022 was $36.00M, a 41.65% decline from fiscal 2021.
- INSULET CORPORATION interest expense for fiscal 2021 was $61.70M, a 28.27% increase from fiscal 2020.
- INSULET CORPORATION interest expense for fiscal 2020 was $48.10M, a 39.02% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $10.70M 10-Q · filed 2024-05-10 | $17.40M derived: sum of 2 quarters · filed 2024-05-10 | $27.80M derived: sum of 3 quarters · filed 2024-05-10 | $37.50M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2023-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $17.10M derived: sum of 2 quarters · filed 2024-02-23 | $26.80M derived: sum of 3 quarters · filed 2024-02-23 | $36.20M 10-K · filed 2024-02-23 | ||||
| 2023-09-30 | $10.40M 10-Q · filed 2023-11-03 | $20.10M derived: sum of 2 quarters · filed 2023-11-03 | $29.50M 10-Q · filed 2023-11-03 | $38.20M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2023-06-30 | $9.70M 10-Q · filed 2023-08-09 | $19.10M 10-Q · filed 2023-08-09 | $27.80M derived: sum of 3 quarters · filed 2024-05-10 | $37.00M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2023-03-31 | $9.40M 10-Q · filed 2024-05-10 | $18.10M derived: sum of 2 quarters · filed 2024-05-10 | $27.30M derived: sum of 3 quarters · filed 2024-05-10 | $36.40M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $17.90M derived: sum of 2 quarters · filed 2024-02-23 | $27.00M derived: sum of 3 quarters · filed 2024-02-23 | $36.00M 10-K · filed 2024-02-23 | $36.50M 10-K · filed 2023-02-24 | |||
| 2022-09-30 | $9.20M 10-Q · filed 2023-11-03 | $18.30M derived: sum of 2 quarters · filed 2023-11-03 | $27.30M 10-Q · filed 2023-11-03 | $42.40M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $9.10M 10-Q · filed 2023-08-09 | $18.10M 10-Q · filed 2023-08-09 | $33.20M derived: sum of 3 quarters · filed 2024-02-23 | $49.60M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $9.00M 10-Q · filed 2023-05-05 | $24.10M derived: sum of 2 quarters · filed 2024-02-23 | $40.50M derived: sum of 3 quarters · filed 2024-02-23 | $57.10M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $15.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $31.50M derived: sum of 2 quarters · filed 2024-02-23 | $48.10M derived: sum of 3 quarters · filed 2024-02-23 | $61.70M 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | $16.40M 10-Q · filed 2022-11-04 | $33.00M derived: sum of 2 quarters · filed 2022-11-04 | $46.60M 10-Q · filed 2022-11-04 | $59.40M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $16.60M 10-Q · filed 2022-08-05 | $30.20M 10-Q · filed 2022-08-05 | $43.00M derived: sum of 3 quarters · filed 2023-02-24 | $54.90M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-03-31 | $13.60M 10-Q · filed 2022-05-06 | $26.40M derived: sum of 2 quarters · filed 2023-02-24 | $38.30M derived: sum of 3 quarters · filed 2023-02-24 | $50.10M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2020-12-31 | $12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $24.70M derived: sum of 2 quarters · filed 2023-02-24 | $36.50M derived: sum of 3 quarters · filed 2023-02-24 | $48.10M 10-K · filed 2023-02-24 | ||||
| 2020-09-30 | $11.90M 10-Q · filed 2021-11-05 | $23.70M derived: sum of 2 quarters · filed 2021-11-05 | $35.30M 10-Q · filed 2021-11-05 | $46.20M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $11.80M 10-Q · filed 2021-08-06 | $23.40M 10-Q · filed 2021-08-06 | $34.30M derived: sum of 3 quarters · filed 2022-02-24 | $43.70M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $11.60M 10-Q · filed 2021-05-07 | $22.50M derived: sum of 2 quarters · filed 2022-02-24 | $31.90M derived: sum of 3 quarters · filed 2022-02-24 | $39.60M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $20.30M derived: sum of 2 quarters · filed 2022-02-24 | $28.00M derived: sum of 3 quarters · filed 2022-02-24 | $34.60M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $9.40M 10-Q · filed 2020-11-05 | $9.37M 10-Q · filed 2019-11-06 | $17.10M derived: sum of 2 quarters · filed 2020-11-05 | $23.70M 10-Q · filed 2020-11-05 | $23.63M 10-Q · filed 2019-11-06 | $30.56M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-06-30 | $7.70M 10-Q · filed 2020-08-07 | $7.64M 10-Q · filed 2019-08-06 | $14.30M 10-Q · filed 2020-08-07 | $14.26M 10-Q · filed 2019-08-06 | $21.16M derived: sum of 3 quarters · filed 2021-02-24 | $28.00M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-03-31 | $6.60M 10-Q · filed 2020-05-08 | $13.46M derived: sum of 2 quarters · filed 2021-02-24 | $20.30M derived: sum of 3 quarters · filed 2021-02-24 | $27.59M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $6.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $13.70M derived: sum of 2 quarters · filed 2021-02-24 | $20.99M derived: sum of 3 quarters · filed 2021-02-24 | $28.90M 10-K · filed 2021-02-24 | $28.90M 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $6.85M 10-Q · filed 2019-11-06 | $14.14M derived: sum of 2 quarters · filed 2019-11-06 | $22.04M 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | $7.29M 10-Q · filed 2019-08-06 | $15.21M 10-Q · filed 2019-08-06 | ||||||
| 2017-12-31 | $21.20M 10-K · filed 2020-02-26 | $21.21M 10-K · filed 2018-02-22 | ||||||
| 2016-12-31 | $14.39M 10-K · filed 2019-02-26 | |||||||
| 2015-12-31 | $12.71M 10-K · filed 2018-02-22 | |||||||
| 2014-06-30 | $300.00K 10-Q · filed 2014-08-07 | $600.00K 10-Q · filed 2014-08-07 | ||||||
| 2014-03-31 | $300.00K 10-Q · filed 2014-05-07 | |||||||
| 2013-09-30 | $100.00K 10-Q · filed 2013-11-07 | $100.00K derived: sum of 2 quarters · filed 2014-08-07 | $100.00K 10-Q · filed 2013-11-07 | |||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |